UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
FORM 8-K
CURRENT REPORT

 
Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934

Date of Report (Date of earliest event reported):
May 24, 2013
 
THE DOW CHEMICAL COMPANY
 
(Exact name of registrant as specified in its charter)
 
Delaware
(State or other jurisdiction
of incorporation)
1-3433
(Commission File Number)
 
38-1285128
(IRS Employer
Identification No.)
   
2030 Dow Center, Midland, Michigan
(Address of principal executive offices)
48674
(Zip Code)
   
(989) 636-1000
(Registrant’s telephone number, including area code)
 
N.A.
(Former name or former address, if changed since last report)

 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
 
o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 
o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
 
o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
 
o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 
 


 
 
 
 
 
    
Item 7.01
Regulation FD Disclosure

On May 24, 2013, The Dow Chemical Company (the “Company”) announced the redemption of $1.25 billion aggregate principal amount of the Company’s 5.90% Notes due 2015.  A copy of the press release is attached hereto as Exhibit 99.1.

This information is furnished pursuant to Item 7.01 of Form 8-K.  The information in this report shall not be treated as filed for purposes of the Securities Exchange Act of 1934, as amended.

The furnishing of the information in this Item 7.01 is not intended to, and does not, constitute a representation that such furnishing is required by Regulation FD or that the information in this Item 7.01 is material information that is not otherwise publicly available.


Item 9.01
Financial Statements and Exhibits

(d)
Exhibits.
 
 
Exhibit No.
Description
 
 
99.1
Press release issued by The Dow Chemical Company on May 24, 2013.


 
 
 
 
 
 
 
 
 
 
 
 

 
 
SIGNATURE
 
Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
THE DOW CHEMICAL COMPANY
Registrant

 
Dated:  May 24, 2013
 
       
  By:   /s/ RONALD C. EDMONDS  
    Name: Ronald C. Edmonds  
    Title: Vice President and Controller  
         

 
 
 
 
 
 
 
 
 
 
 
 

 

 
EXHIBIT INDEX
 
Exhibit No.
Description
 
 
99.1
Press release issued by The Dow Chemical Company on May 24, 2013.